Frontier IP Group Plc (FIPP.L) Announced that portfolio company Exscientia ("Exscientia" or the "Company"), a world leader in
artificial intelligence ("AI") drug discovery, has entered into a drug discovery collaboration with
Rallybio. Rallybio is a US-based drug development company aiming to transform the lives of patients
with rare diseases.